Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for MedWellAI (MWAI) over the last 9 years, with Q3 2025 value amounting to $6.2 million.

  • MedWellAI's Shares Outstanding (Diluted Average) rose 2185.13% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 2185.13%. This contributed to the annual value of $5.7 million for FY2025, which is 2927.96% up from last year.
  • Per MedWellAI's latest filing, its Shares Outstanding (Diluted Average) stood at $6.2 million for Q3 2025, which was up 2185.13% from $5.7 million recorded in Q2 2025.
  • MedWellAI's 5-year Shares Outstanding (Diluted Average) high stood at $291.2 million for Q4 2021, and its period low was $2.0 million during Q4 2022.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $60.2 million, with a median of $5.3 million in 2024.
  • As far as peak fluctuations go, MedWellAI's Shares Outstanding (Diluted Average) plummeted by 9931.3% in 2022, and later surged by 68151.23% in 2024.
  • MedWellAI's Shares Outstanding (Diluted Average) (Quarter) stood at $291.2 million in 2021, then tumbled by 99.31% to $2.0 million in 2022, then soared by 111.37% to $4.2 million in 2023, then increased by 25.74% to $5.3 million in 2024, then grew by 16.35% to $6.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $6.2 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.9 million in Q1 2025.